The store will not work correctly when cookies are disabled.
2-(3,4-dimethoxyphenyl)-6-methoxy-4H-chromen-4-one
ID: ALA5201647
Cas Number: 370583-46-3
PubChem CID: 803908
Max Phase: Preclinical
Molecular Formula: C18H16O5
Molecular Weight: 312.32
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc2oc(-c3ccc(OC)c(OC)c3)cc(=O)c2c1
Standard InChI: InChI=1S/C18H16O5/c1-20-12-5-7-15-13(9-12)14(19)10-17(23-15)11-4-6-16(21-2)18(8-11)22-3/h4-10H,1-3H3
Standard InChI Key: QYDMYMLHNGOWLE-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
1.4313 -0.2053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1434 0.2112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1434 1.0327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4267 1.4455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7133 1.0347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7133 0.2091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0015 -0.2036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0015 -1.0290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7163 -1.4418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7163 -2.2673 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.4313 -1.0290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1417 -1.4409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8583 -1.0327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8583 -0.2039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1435 0.2084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4313 -0.2035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7163 0.2091 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.5732 -1.4455 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.5732 -2.2709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8567 1.4454 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8567 2.2709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8583 -0.2014 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5732 0.2112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
8 7 2 0
9 8 1 0
9 10 2 0
11 9 1 0
12 11 1 0
13 12 2 0
14 13 1 0
15 14 2 0
16 15 1 0
11 16 2 0
16 17 1 0
7 17 1 0
13 18 1 0
18 19 1 0
3 20 1 0
20 21 1 0
2 22 1 0
22 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 312.32 | Molecular Weight (Monoisotopic): 312.0998 | AlogP: 3.49 | #Rotatable Bonds: 4 |
Polar Surface Area: 57.90 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.49 | CX LogD: 2.49 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.74 | Np Likeness Score: 0.25 |
References
1. Kampschulte N, Berking T, Çelik IE, Kirsch SF, Schebb NH.. (2022) Inhibition of cytochrome P450 monooxygenase-catalyzed oxylipin formation by flavonoids: Evaluation of structure-activity relationship towards CYP4F2-selective inhibitors., 238 [PMID:35576701] [10.1016/j.ejmech.2022.114332] |